VIATRIS INC (VTRS)
US92556V1061 - Common Stock
Tuesday Sector Laggards: Healthcare, Materials
Gapping S&P500 stocks in Tuesday's session
Curious about the market action on Tuesday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.
S&P 500 Movers: ENPH, PLTR
Viatris Announces Publication of Phase 2b CARE Study Data for Cenerimod in Lancet Rheumatology
/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced the publication of Phase 2b CARE study results evaluating the efficacy and safety of cenerimod in...
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Thursday.
Top movers analysis in the middle of the day of S&P500 on 2024-12-12: top gainers and losers in today's session.
Tradeweb Markets Larger Than S&P 500 Component Viatris
Entegris Larger Than S&P 500 Component Viatris
Aspen Technology Moves Up In Market Cap Rank, Passing Viatris
YieldBoost VTRS To 8.9% Using Options
Viatris Announces Third Quarter 2024 Dividend
/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that on November 4, 2024, its Board of Directors declared a quarterly dividend of $0.12 per share...
Viatris Named to Forbes' World's Top Companies for Women 2024 List
/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has been named to Forbes' World's Top Companies for Women...
XPO Larger Than S&P 500 Component Viatris
Avangrid Larger Than S&P 500 Component Viatris
Equitable Holdings Moves Up In Market Cap Rank, Passing Viatris
AECOM Larger Than S&P 500 Component Viatris
Viatris Announces Exclusive Licensing Agreement with Lexicon Pharmaceuticals for Sotagliflozin in all Markets Outside of the U.S. and Europe
/PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced it has entered into an exclusive licensing agreement with Lexicon...
Viatris Announces Positive Top-line Results from Phase 3 Study of EFFEXOR® in Japanese Adults with Generalized Anxiety Disorder (GAD)
/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced positive top-line results of its Phase 3 study (B2411367) in Japan...
Viatris Named to Forbes' Annual List of the World's Best Employers for the Fourth Year in a Row
/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has been named to Forbes' list of World's Best Employers 2024....
Viatris Announces the Pricing Terms of Maximum Tender Offer
/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS, "Viatris" or the "Company") announced today the pricing terms of the previously announced cash tender offer (the...
Viatris Announces Early Tender Results and Increase of Pending Maximum Tender Offer
/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS, "Viatris" or the "Company") announced today the early tender results of the previously announced cash tender offer...
Viatris to Report Third Quarter 2024 Financial Results on November 7, 2024
/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will report its third quarter 2024 financial results on Thursday, November 7, 2024, before the open of the U.S....
Viatris Announces Expiration and Results of Any and All Cash Tender Offers
/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS, "Viatris" or the "Company") announced today that the previously announced cash tender offers (the "Any and All...
Viatris Announces the Pricing Terms of Pending Any and All Cash Tender Offers
/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS, "Viatris" or the "Company") announced today the pricing terms of the previously announced cash tender offers (the...
Viatris Announces Cash Tender Offers for Certain Outstanding Notes
/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS, "Viatris" or the "Company") announced today that it and its subsidiaries, Mylan Inc. ("Mylan") and Utah Acquisition...
Viatris Moves Up In Market Cap Rank, Passing Bunge Global
Viatris Presents Late Breaking Abstract on Cenerimod at the 26th Asia-Pacific League of Associations for Rheumatology Annual Congress
/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, presented today the results of one of its Phase 2 studies* of cenerimod (ACT-333441)....
3 Top Value Stocks to Buy Right Now
Value stocks offer potential for significant returns in today's overheated market.
Wednesday Sector Laggards: Materials, Healthcare